DFX Intelligence
Venture Capital Intelligence
Firms, funds, partners, companies and rounds from sworn filings, firm sites and announcements, kept as a graph with a date and a source on every edge. Facts, inferences and estimates are labelled as such. A fund target is never a close, GAV is never dry powder, and a round size is never an investor’s check.
People / Andrew Levin
Andrew Levin
Roles
1 current, 0 past
Investments attributed to this person
0
No investment attributed yet. Attribution needs a source naming this person on the deal: a quote, a board seat, a portfolio page credit.
Board seats and vehicles
6 boards, 0 vehicles
- Climb Bio, Inc. Director May 4, 2026 Fact
- Superluminal Medicines, Inc. Director Sep 4, 2024 Fact
- Imbria Pharmaceuticals, Inc. Director Apr 1, 2025 Fact
- Pahr Therapeutics, Inc. Director Jul 18, 2025 Fact
- Slate Medicines, Inc. Director Mar 11, 2026 Fact
- Solstice Oncology, Inc. Director Mar 9, 2026 Fact
Timeline
0
No dated event.